Literature DB >> 2537932

Phase variation in Bordetella pertussis by frameshift mutation in a gene for a novel two-component system.

S Stibitz1, W Aaronson, D Monack, S Falkow.   

Abstract

Bordetella pertussis, the aetiological agent of whooping cough, coordinately regulates the expression of many virulence-associated determinants, including filamentous haemagglutinin, pertussis toxin, adenylyl cyclase toxin, dermonecrotic toxin and haemolysin. The coordinate regulation is apparent in the repression of synthesis of these determinants in response to environmental stimuli; a phenomenon known as antigenic or phenotypic modulation. B. pertussis also varies between metastable genetic states, or phases. There is a virulent phase in which virulence-associated determinants are synthesized, and an avirulent phase in which they are not. Previous studies have shown that a genetic locus, vir, is required for expression from many virulence-associated loci, and that replacing the cloned vir locus in trans can restore the virulent phase phenotype to spontaneously occurring avirulent phase strains. Here, we show that phase variation in one series of strains is due to a frameshift mutation within an open reading frame that is predicted to code for a Vir protein product. The deduced protein sequence is similar to both components of the 'two-component' regulatory system which control gene expression in response to environmental stimuli in a range of bacterial species.

Entities:  

Mesh:

Year:  1989        PMID: 2537932     DOI: 10.1038/338266a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  93 in total

1.  Genetic and biochemical analyses of BvgA interaction with the secondary binding region of the fha promoter of Bordetella pertussis.

Authors:  P E Boucher; M S Yang; D M Schmidt; S Stibitz
Journal:  J Bacteriol       Date:  2001-01       Impact factor: 3.490

2.  Stereotyped and specific gene expression programs in human innate immune responses to bacteria.

Authors:  Jennifer C Boldrick; Ash A Alizadeh; Maximilian Diehn; Sandrine Dudoit; Chih Long Liu; Christopher E Belcher; David Botstein; Louis M Staudt; Patrick O Brown; David A Relman
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

Review 3.  Phase and antigenic variation in bacteria.

Authors:  Marjan W van der Woude; Andreas J Bäumler
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

4.  Identification of a gene, rgg, which regulates expression of glucosyltransferase and influences the Spp phenotype of Streptococcus gordonii Challis.

Authors:  M C Sulavik; G Tardif; D B Clewell
Journal:  J Bacteriol       Date:  1992-06       Impact factor: 3.490

5.  Analysis of bvgR expression in Bordetella pertussis.

Authors:  Tod J Merkel; Philip E Boucher; Scott Stibitz; Vanessa K Grippe
Journal:  J Bacteriol       Date:  2003-12       Impact factor: 3.490

6.  Use of oligonucleotide probes to identify members of two-component regulatory systems in Xanthomonas campestris pathovar campestris.

Authors:  A E Osbourn; B R Clarke; B J Stevens; M J Daniels
Journal:  Mol Gen Genet       Date:  1990-06

Review 7.  The Bordetella pertussis model of exquisite gene control by the global transcription factor BvgA.

Authors:  Kimberly B Decker; Tamara D James; Scott Stibitz; Deborah M Hinton
Journal:  Microbiology       Date:  2012-05-24       Impact factor: 2.777

8.  The bvgA gene of Bordetella pertussis encodes a transcriptional activator required for coordinate regulation of several virulence genes.

Authors:  C R Roy; J F Miller; S Falkow
Journal:  J Bacteriol       Date:  1989-11       Impact factor: 3.490

9.  Analysis of Bordetella pertussis virulence gene regulation by use of transcriptional fusions in Escherichia coli.

Authors:  J F Miller; C R Roy; S Falkow
Journal:  J Bacteriol       Date:  1989-11       Impact factor: 3.490

10.  Contribution of regulation by the bvg locus to respiratory infection of mice by Bordetella pertussis.

Authors:  T J Merkel; S Stibitz; J M Keith; M Leef; R Shahin
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.